Nanjing Leads Biolabs Co Ltd Sustainability Reports
Nanjing Leads Biolabs Co., Ltd. is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative antibody therapies for oncology and autoimmune diseases.
Sector: Professional & technical services
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01W4G5HT4
1 reports from 2025 to 2025
